Session » RA – Diagnosis, Manifestations, & Outcomes Poster I: Multimorbidity

Date: Friday, November 6, 2020

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2020

9:00AM-11:00AM: Abstract Number: 0198

A Prospective Cohort Study of Vehicle Control as a Measure of Driving Performance in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 0177

Association of Hydroxychloroquine Use with Development of Non-Alcoholic Fatty Liver Disease in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 0178

Associations of Multimorbidity with DMARD Initiation and Achieving Target Disease Activity Thresholds in Active Rheumatoid Arthritis: A Cohort Study Using the Rheumatology Informatics System for Effectiveness (RISE) Registry

9:00AM-11:00AM: Abstract Number: 0182

Chronic Kidney Disease Is Underestimated in Patients with Rheumatoid Arthritis – Real World Data Gathered from a Network of Rheumatologists

9:00AM-11:00AM: Abstract Number: 0180

Clinicopathological Characteristics of Lymphoproliferative Disorders in 232 Patients with Rheumatoid Arthritis in Japan

9:00AM-11:00AM: Abstract Number: 0194

Depression Symptoms but Not Clinically Diagnosed Depression Predict Mortality in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 0189

Determining the Relationship Between Mycobacterium Avium Subspecies Paratuberculosis Serostatus, Dietary Habits, Medication Regimen, and Joint Pain in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 0195

Epidemiology and Characteristics of Incident Rheumatoid Arthritis in Persons with and Without HIV

9:00AM-11:00AM: Abstract Number: 0190

Hepatic Steatosis in Rheumatoid Arthritis: Frequency and Disease-Related Contributors

9:00AM-11:00AM: Abstract Number: 0179

Identification of Multimorbidity Patterns in Rheumatoid Arthritis Through Machine Learning

9:00AM-11:00AM: Abstract Number: 0183

Incidence of Malignancies in Japanese Patients with Rheumatoid Arthritis: Data from a Large Japanese National Registry

9:00AM-11:00AM: Abstract Number: 0191

Increased Frequency of Lower Limb Arterial Obstruction in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 0192

Influence of Inflammatory and Non-inflammatory Rheumatic Disorders on the Clinical and Biological Profile of Adult-onset Diabetes

9:00AM-11:00AM: Abstract Number: 0184

Lymphomas Complicating Rheumatoid Arthritis: Results of a French Multi-Centre Case-Control Study

9:00AM-11:00AM: Abstract Number: 0181

Methotrexate Use Does Not Increase the Prevalence of Hepatic Steatosis: A Real-World Retrospective Nested Case-Control Study

9:00AM-11:00AM: Abstract Number: 0196

Objectively-Measured Obstructive Sleep Apnea Is Frequent Among Individuals with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 0193

Patients with Asthma Have a Higher Risk of Rheumatoid Arthritis: A Systematic Review and Meta-analysis

9:00AM-11:00AM: Abstract Number: 0185

Prevalence of Migraine and Neuropathic Pain in Rheumatic Disease

9:00AM-11:00AM: Abstract Number: 0187

Regional and Widespread Patterns of Non-articular Pain Are Common at RA Diagnosis and Contribute to Poor Outcomes at 12 Months: A Prospective Study of Pain Patterns in Canadians with RA

9:00AM-11:00AM: Abstract Number: 0197

The Clinical and Laboratory Features of Seronegative Rheumatoid Arthritis with and Without Malignancy

9:00AM-11:00AM: Abstract Number: 0186

The Number of Associated Comorbidities Can Impact Disease Activity Scores Independently from Objective Measures of Inflammation in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 0188

The Risk of Fractures in a Community-based Cohort of Patients with Rheumatoid Arthritis Compared with the Background Population

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].